cover image Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-april-2024 About Prime Therapeutics Prime Therapeutics...

cover image Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-january-2024 About Prime Therapeutics Prime Therapeutics...

cover image Tracking the therapies shaping tomorrow’s care Prime Therapeutics /cell-gene-pipeline-outlook-november-2025 Prime Therapeutics’ Cell & Gene Pipeline Outlook is an industry report that...

As GLP-1 use expands, persistence remains a critical factor in realizing the therapies' full clinical potential

Event on Sept. 11 in Washington D.C. will feature the latest information on using GLP-1s to tackle the obesity epidemic.

Prime Therapeutics researchers shared real-world insights at AMCP Nexus 2025 on GLP-1 utilization, treatment persistence and strategies to improve access to these high-demand therapies

Real-world, integrated data follows-up on previous insights, analytics.

PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market All brand names are property of their respective owners. References Press release:...